Avenue Therapeutics SG&A Expense (TTM) Analysis

Avenue Therapeutics Inc (ATXI)

2.09 -0.23 (-9.91%) USD | NASDAQ | Oct 04, 16:00

2.09 0.00 (0.00%) After-Hours: 17:48

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
June 30, 2024	5.076M
March 31, 2024	4.51M
December 31, 2023	4.178M
September 30, 2023	6.408M
June 30, 2023	5.716M
March 31, 2023	5.274M
December 31, 2022	5.345M
September 30, 2022	2.502M
June 30, 2022	2.627M
March 31, 2022	2.796M
December 31, 2021	2.484M
September 30, 2021	2.475M
June 30, 2021	2.452M
March 31, 2021	2.513M
December 31, 2020	2.347M
September 30, 2020	2.451M

Date	Value
June 30, 2020	2.497M
March 31, 2020	2.529M
December 31, 2019	3.071M
September 30, 2019	3.839M
June 30, 2019	4.042M
March 31, 2019	4.253M
December 31, 2018	4.12M
September 30, 2018	3.837M
June 30, 2018	3.865M
March 31, 2018	4.235M
December 31, 2017	3.62M
September 30, 2017	2.82M
June 30, 2017	2.172M
March 31, 2017	1.092M
December 31, 2016	0.997M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

2.347M

Minimum

Dec 2020

6.408M

Maximum

Sep 2023

3.540M

Average

2.627M

Median

Jun 2022

SG&A Expense (TTM) Benchmarks